<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="micc70012" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microcirculation</journal-id><journal-id journal-id-type="iso-abbrev">Microcirculation</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1549-8719</journal-id><journal-id journal-id-type="publisher-id">MICC</journal-id><journal-title-group><journal-title>Microcirculation (New York, N.y. : 1994)</journal-title></journal-title-group><issn pub-type="ppub">1073-9688</issn><issn pub-type="epub">1549-8719</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40394906</article-id><article-id pub-id-type="pmc">PMC12093041</article-id><article-id pub-id-type="doi">10.1111/micc.70012</article-id><article-id pub-id-type="publisher-id">MICC70012</article-id><article-id pub-id-type="other">UMIC-2024-0150.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>ORIGINAL ARTICLE</subject><subj-group subj-group-type="heading"><subject>Microcirculation From Head to Toe</subject></subj-group></subj-group></article-categories><title-group><article-title>Oxidized Cell&#x02010;Free Hemoglobin Induces Mitochondrial Dysfunction by Activation of the Mitochondrial Permeability Transition Pore in the Pulmonary Microvasculature</article-title></title-group><contrib-group><contrib id="micc70012-cr-0001" contrib-type="author" corresp="yes"><name><surname>Riedmann</surname><given-names>Kyle J.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8708-8687</contrib-id><xref rid="micc70012-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="micc70012-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>kyle.j.riedmann@vanderbilt.edu</email></address></contrib><contrib id="micc70012-cr-0002" contrib-type="author"><name><surname>Meegan</surname><given-names>Jamie E.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2644-676X</contrib-id><xref rid="micc70012-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="micc70012-cr-0003" contrib-type="author"><name><surname>Afzal</surname><given-names>Aqeela</given-names></name><xref rid="micc70012-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="micc70012-cr-0004" contrib-type="author"><name><surname>Cervantes&#x02010;Cruz</surname><given-names>Yatzil</given-names></name><xref rid="micc70012-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="micc70012-cr-0005" contrib-type="author"><name><surname>Obeidalla</surname><given-names>Sarah</given-names></name><xref rid="micc70012-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="micc70012-cr-0006" contrib-type="author"><name><surname>Bogart</surname><given-names>Avery M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3912-3177</contrib-id><xref rid="micc70012-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="micc70012-cr-0007" contrib-type="author"><name><surname>Ware</surname><given-names>Lorraine B.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9429-4702</contrib-id><xref rid="micc70012-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="micc70012-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="micc70012-cr-0008" contrib-type="author"><name><surname>Shaver</surname><given-names>Ciara M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5677-0288</contrib-id><xref rid="micc70012-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="micc70012-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="micc70012-cr-0009" contrib-type="author"><name><surname>Bastarache</surname><given-names>Julie A.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0458-6507</contrib-id><xref rid="micc70012-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="micc70012-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="micc70012-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="micc70012-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Cell and Developmental Biology</named-content>
<institution>Vanderbilt University</institution>
<city>Nashville</city>
<named-content content-type="country-part">Tennessee</named-content>
<country country="US">USA</country>
</aff><aff id="micc70012-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Division of Allergy, Pulmonary, and Critical Care Medicine</named-content>
<institution>Vanderbilt University Medical Center</institution>
<city>Nashville</city>
<named-content content-type="country-part">Tennessee</named-content>
<country country="US">USA</country>
</aff><aff id="micc70012-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Neurosurgery</named-content>
<institution>Vanderbilt University Medical Center</institution>
<city>Nashville</city>
<named-content content-type="country-part">Tennessee</named-content>
<country country="US">USA</country>
</aff><aff id="micc70012-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Pathology, Microbiology, and Immunology</named-content>
<institution>Vanderbilt University</institution>
<city>Nashville</city>
<named-content content-type="country-part">Tennessee</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Kyle J. Riedmann (<email>kyle.j.riedmann@vanderbilt.edu</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2025</year></pub-date><volume>32</volume><issue seq="50">4</issue><issue-id pub-id-type="doi">10.1111/micc.v32.4</issue-id><elocation-id>e70012</elocation-id><history>
<date date-type="rev-recd"><day>02</day><month>4</month><year>2025</year></date>
<date date-type="received"><day>03</day><month>1</month><year>2025</year></date>
<date date-type="accepted"><day>08</day><month>5</month><year>2025</year></date>
</history><permissions><!--Copyright &#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Microcirculation</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:MICC-32-e70012.pdf"/><abstract><title>ABSTRACT</title><sec id="micc70012-sec-0001"><title>Objective</title><p>Cell&#x02010;free hemoglobin (CFH) is released into the circulation during sepsis where it can redox cycle from the ferrous 2+ to ferric 3+ and disrupt endothelial function, but the mechanisms of CF&#x02010;mediated endothelial dysfunction are unknown. We hypothesized that oxidized CFH induces mitochondrial dysfunction via the mitochondrial permeability transition pore (mPTP) in pulmonary endothelial cells, leading to the release of mitochondrial DNA (mtDNA).</p></sec><sec id="micc70012-sec-0002"><title>Methods</title><p>Human lung microvascular endothelial cells were treated with CFH2+/CFH3+. We measured mitochondrial mPTP activation (flow cytometry), network and mass (immunostaining), structure (electron microscopy), mtDNA release (PCR), and oxygen consumption rate (OCR; Seahorse). Plasma from critically ill patients and conditioned cell media were quantified for mtDNA and CFH.</p></sec><sec id="micc70012-sec-0003"><title>Results</title><p>CFH3+ disrupted the mitochondrial network, activated the mPTP (1434 (874&#x02013;1642) vs. 2302 (1729&#x02013;2654) mean fluorescent intensity, <italic toggle="no">p</italic>&#x02009;=&#x02009;0.02), increased the spare respiratory capacity (30.61 (29.36&#x02013;37.78) vs. 7.83 (3.715&#x02013;10.63) OCR, <italic toggle="no">p</italic>&#x02009;=&#x02009;0.004), and caused the release of mtDNA. CFH was associated with circulating mtDNA (<italic toggle="no">R</italic>
<sup>2</sup>&#x02009;=&#x02009;0.1912, <italic toggle="no">p</italic>&#x02009;=&#x02009;0.0077) in plasma from critically ill patients.</p></sec><sec id="micc70012-sec-0004"><title>Conclusion</title><p>CFH3+, not CFH2+, is the primary driver of CFH&#x02010;induced lung microvascular mitochondrial dysfunction. Activation of the mPTP and the release of mtDNA are a feature of CFH3+ mediated injury.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="micc70012-kwd-0001">cell&#x02010;free hemoglobin</kwd><kwd id="micc70012-kwd-0002">mitochondrial dysfunction</kwd><kwd id="micc70012-kwd-0003">mitochondrial permeability transition pore</kwd><kwd id="micc70012-kwd-0004">mtDNA</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Institutes of Health
</institution><institution-id institution-id-type="doi">10.13039/100000002</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="6"/><table-count count="1"/><page-count count="12"/><word-count count="7200"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:21.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="micc70012-ntgp-0001"><fn fn-type="funding" id="micc70012-note-0001"><p>
<bold>Funding:</bold> This study was supported by the National Institutes of Health (grant numbers HL150783, AG075341, GM144915, HL158906 and HL167471).</p></fn></fn-group></notes></front><body id="micc70012-body-0001"><sec id="micc70012-sec-0005"><label>1</label><title>Introduction</title><p>Sepsis results from a dysregulated immune response to an infection [<xref rid="micc70012-bib-0001" ref-type="bibr">1</xref>] and remains a critical problem accounting for ~20% of global deaths [<xref rid="micc70012-bib-0002" ref-type="bibr">2</xref>]. The highly inflammatory environment during sepsis causes systemic damage to organs and the vascular system [<xref rid="micc70012-bib-0003" ref-type="bibr">3</xref>]. In the lungs, this manifests as pulmonary microvasculature disruption leading to alveolar edema, leukocyte migration, and vasodilation [<xref rid="micc70012-bib-0003" ref-type="bibr">3</xref>, <xref rid="micc70012-bib-0004" ref-type="bibr">4</xref>]. The pulmonary microvascular endothelium is critical for maintaining tissue homeostasis and barrier function of the alveolar&#x02010;capillary barrier [<xref rid="micc70012-bib-0005" ref-type="bibr">5</xref>]. Endothelial dysfunction results in part from circulating inflammatory mediators, microbial products, and damage&#x02010;associated molecular patterns (DAMPs) [<xref rid="micc70012-bib-0006" ref-type="bibr">6</xref>, <xref rid="micc70012-bib-0007" ref-type="bibr">7</xref>, <xref rid="micc70012-bib-0008" ref-type="bibr">8</xref>]. Cell&#x02010;free hemoglobin (CFH) is a DAMP released from damaged red blood cells (RBC) and is elevated in ~80% of critically ill patients with sepsis [<xref rid="micc70012-bib-0009" ref-type="bibr">9</xref>]. CFH is a known driver of pulmonary vascular dysfunction via several mechanisms including signaling through toll&#x02010;like receptor 4 (TLR4), activation of the NLR family pyrin domain&#x02010;containing protein 3 (NLRP3) inflammasome, and generation of reactive oxygen species (ROS) [<xref rid="micc70012-bib-0010" ref-type="bibr">10</xref>, <xref rid="micc70012-bib-0011" ref-type="bibr">11</xref>, <xref rid="micc70012-bib-0012" ref-type="bibr">12</xref>, <xref rid="micc70012-bib-0013" ref-type="bibr">13</xref>, <xref rid="micc70012-bib-0014" ref-type="bibr">14</xref>, <xref rid="micc70012-bib-0015" ref-type="bibr">15</xref>]. The significant increase in ROS caused by CFH suggests that downstream ROS&#x02010;sensitive mitochondrial processes may be implicated in mediating CFH&#x02010;induced endothelial dysfunction.</p><p>Circulating CFH can redox cycle between the ferrous (CFH2+) and ferric (CFH3+, methemoglobin) iron forms, generating ROS [<xref rid="micc70012-bib-0015" ref-type="bibr">15</xref>]. The effects of CFH on the endothelium include increased barrier permeability, leukocyte adhesion, and oxidative damage [<xref rid="micc70012-bib-0010" ref-type="bibr">10</xref>, <xref rid="micc70012-bib-0016" ref-type="bibr">16</xref>, <xref rid="micc70012-bib-0017" ref-type="bibr">17</xref>, <xref rid="micc70012-bib-0018" ref-type="bibr">18</xref>]. Studies evaluating these effects on the endothelium have focused on the previously mentioned pathways, but perturbations to mitochondrial function have also been reported. In alveolar epithelial cells, CFH3+ induces translocation of heme oxygenase 1 (HO&#x02010;1) to the mitochondria and causes partial depolarization of the mitochondrial network [<xref rid="micc70012-bib-0019" ref-type="bibr">19</xref>]. Disruption of mitochondrial function in endothelial cells has been linked to impaired proliferation and nitric oxide (NO) signaling [<xref rid="micc70012-bib-0020" ref-type="bibr">20</xref>]. The precise mitochondrial dynamics that occur during CFH&#x02010;induced endothelial dysfunction remain unclear. Analysis of these changes to mitochondrial function by CFH offers insight into molecular mechanisms underlying CFH&#x02010;induced endothelial dysfunction and additionally downstream how mitochondrial products are released in response to mitochondrial dysfunction.</p><p>This study aims to evaluate the differential effects of CFH2+ and CFH3+ on mitochondrial structure and function in the pulmonary microvascular endothelium. We hypothesize that CFH3+ induces mitochondrial dysfunction in endothelial cells as evidenced by changes in mitochondrial mass, polarization, morphology, and oxidative respiration, resulting in activation of the mPTP and release of mtDNA.</p></sec><sec id="micc70012-sec-0006"><label>2</label><title>Methods and Materials</title><sec id="micc70012-sec-0007"><label>2.1</label><title>Cells and Culture Conditions</title><p>Primary human lung microvascular endothelial cells (HLMVECs) were purchased from PromoCell (C&#x02010;12281; Heidelberg, Germany) and cultured in Endothelial Cell Growth Media MV2 (C&#x02010;22121; PromoCell). Cells were grown to confluence on tissue culture plates coated with Attachment Factor Protein (S006100; Gibco) in a humidified 5% CO<sub>2</sub> incubator at 37&#x000b0;C. Hemoglobin was isolated, purified, and oxidized via UV irradiation for 3&#x02009;h with a 10&#x02009;min break every 30&#x02009;min to prevent overheating as previously described [<xref rid="micc70012-bib-0021" ref-type="bibr">21</xref>]. Cells were treated with purified cell&#x02010;free hemoglobin (CFH) diluted in PBS at 1.0&#x02009;mg/mL or PBS vehicle control at timepoints ranging from 1 to 24&#x02009;h [<xref rid="micc70012-bib-0017" ref-type="bibr">17</xref>, <xref rid="micc70012-bib-0018" ref-type="bibr">18</xref>, <xref rid="micc70012-bib-0022" ref-type="bibr">22</xref>, <xref rid="micc70012-bib-0023" ref-type="bibr">23</xref>, <xref rid="micc70012-bib-0024" ref-type="bibr">24</xref>]. In some experiments, cells were pre&#x02010;treated for 1&#x02009;h with haptoglobin (Hp; gift from CSL Behring) at a 2:1&#x02009;M ratio (15.5&#x02009;&#x003bc;M, human plasma purified). Hp is the endogenous CFH scavenger that reliably ameliorates the effects of CFH and is used as a negative control. Hp works through structural stabilization and prevention of oxidative reactions when bound to CFH [<xref rid="micc70012-bib-0025" ref-type="bibr">25</xref>]. All experiments were conducted with HLMVECs from at least one male and one female donor, up to three male and two female donors depending on availability, and HLMVECs were used below passage 7 at full confluency.</p></sec><sec id="micc70012-sec-0008"><label>2.2</label><title>Widefield Fluorescent Microscopy</title><p>Cells were plated and cultured on black 96&#x02010;well plates coated with Attachment Factor (S006100; Gibco) and allowed to reach confluency. Cells were treated with vehicle, CFH2+, CFH3+ (1.0&#x02009;mg/mL), or paraquat (5&#x02009;mM) for 6&#x02009;h prior to staining with CellROX Deep Red (5 uM) or MitoTracker Green (100&#x02009;nM) for 30&#x02009;min at 37&#x000b0;C. Hp pretreatment for 1&#x02009;h was performed for CellROX experiments. Cells were fixed and DNA counterstained as above. Plates were imaged on Lionheart FX (BioTek Instruments Inc., Winooski, VT) with 2 &#x000d7;&#x02009;2 montage at &#x000d7;4 magnification using the DAPI and FITC or RFP channels for MitoTracker Green or CellROX Deep Red, respectively. Analysis was performed on a secondary mask of Hoechst (500&#x02009;ng/mL) stained cells to quantify the object mean fluorescence intensity (MFI) to generate a cell number independent value.</p></sec><sec id="micc70012-sec-0009"><label>2.3</label><title>Mitochondrial <styled-content style="fixed-case" toggle="no">ROS</styled-content>, Membrane Polarization, and <styled-content style="fixed-case" toggle="no">mPTP</styled-content> Activation</title><p>HLMVECs were grown in 6&#x02010;well plates until confluency before treatment with Vehicle (PBS, 1:10), CFH2+, or CFH3+ (1.0&#x02009;mg/mL) for either 6 or 24&#x02009;h depending on the assay. For the flow assays, HLMVECs were washed once with PBS, incubated with TrypLE Express Enzyme (12&#x02009;604&#x02009;013; Gibco) at 37C for 3&#x02013;5&#x02009;min for detachment, collected into prewarmed complete media prior to centrifugation at 500&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 5&#x02009;min to pellet the cells. For the mPTP assay, cell pellets were incubated with the combination of calcein&#x02010;AM and cobalt chloride included in the MitoProbe Transition Pore Assay Kit (M34153; Invitrogen, Carlsbad, CA) in HBSS (21&#x02010;020CV; Corning, Corning, NY) for 30&#x02009;min in a 37&#x000b0;C incubator. Cells were analyzed using a LSRFortessa (BD, Franklin Lakes, NJ) in the FITC channel to obtain the MFI. For the MitoSOX Deep Red experiments, cells were stained (5 uM) in 6&#x02010;well plates after treatment for 30&#x02009;min at 37&#x000b0;C before harvesting as described above. Cells were analyzed on an LSRFortessa using the PE filter set. Both the mPTP and MitoSOX assays required minimal compensation with unstained cells and the single channel for the respective dye. For the JC10 assay, the cells were treated and harvested as described above before being resuspended in 1&#x000d7; JC10 in assay buffer (ab112133; Abcam, Cambridge, MA) and incubated at 37&#x000b0;C for 30&#x02009;min prior to analysis on an LSRFortessa using the FITC and PE filter sets to obtain the PE:FITC ratio. Spectral compensation was performed on unstained, JC10 stained cells (PE channel), and JC10 stained cells treated with FCCP (2.5 uM, FITC channel). FCCP optimization showed the highest FITC:PE ratio was 2.5 &#x003bc;M for 30&#x02009;min at 37&#x000b0;C (Figure&#x000a0;<xref rid="micc70012-supitem-0001" ref-type="supplementary-material">S4</xref>). Data from all flow cytometry experiments were analyzed using FlowJo (FlowJo, Ashland, OR; Version 10.10.0).</p></sec><sec id="micc70012-sec-0010"><label>2.4</label><title>Mitochondrial Morphology by Electron Microscopy</title><p>HLMVECs were grown to confluency in 100&#x02009;mm plates and treated with vehicle, CFH2+, or CFH3+ for 6&#x02009;h. After washing with HBSS, the cells were fixed with 2.5% glutaraldehyde and 1% paraformaldehyde in 0.1&#x02009;M cacodylate buffer for 60&#x02009;min at room temperature. Cell pellets were post&#x02010;fixed sequentially in 1% tannic acid, 1% osmium tetroxide, and en bloc stained in 1% uranyl acetate [<xref rid="micc70012-bib-0026" ref-type="bibr">26</xref>]. Samples were dehydrated in a graded ethanol series and infiltrated with Quetol 651 low viscosity Spurr's Resin using propylene oxide as the transition solvent. The resin was polymerized at 60&#x000b0;C for 48&#x02009;h, sectioned using a Leica Enuity at a nominal thickness of 70&#x02009;nm, and collected onto 300 mesh Ni grids. Sections were stained with 2% uranyl acetate and lead citrate. Samples were imaged either on a ThermoFisher Scientific Tecnai T12 operating at 100&#x02009;keV using an AMT nanosprint 5 CMOS camera or a JEOL 2100 Plus operating at 200&#x02009;keV using an AMT nanosprint 15mkII CMOS camera. Images were obtained at 6500&#x000d7; and 6000&#x000d7; magnification, respectively. Mitochondrial morphology parameters were measured with Fiji, an open&#x02010;source application used for image analysis, on individual mitochondrion by a blinded reviewer [<xref rid="micc70012-bib-0027" ref-type="bibr">27</xref>]. At least 100 mitochondria were measured per group by selection of the mitochondrion using the circular selection tool before taking measurements of the mean intensity (mean electron density), roundness, and circularity. Results are from two male donors with &#x0003e;&#x02009;10 fields of view and &#x0003e;&#x02009;100 mitochondria per group.</p></sec><sec id="micc70012-sec-0011"><label>2.5</label><title>Seahorse Mito Stress Test</title><p>Metabolic assays were performed using the Seahorse Analyzer (Agilent) and the Mito Stress Test (103015&#x02013;100, Agilent) drug packs. HLMVECs were plated at confluency on coated XFe96 (103794&#x02013;100, Agilent) plates and allowed to form a monolayer. Cells were treated with Vehicle, CFH2+, or CFH3+ (1.0&#x02009;mg/mL) for 6&#x02009;h. The Mito Stress Test was performed according to the manufacturer's instructions. Optimized concentrations of the drugs were previously found to be 1.5 uM oligomycin, 1 uM FCCP, and 0.5 uM each of rotenone and antimycin A. The <styled-content style="fixed-case" toggle="no">
<italic toggle="no">media</italic>
</styled-content> used was XF DMEM (103680&#x02013;100, Agilent) with 1&#x02009;mM pyruvate, 2&#x02009;mM glutamine, and 10&#x02009;mM glucose. Oxygen consumption rates were normalized to cell count per well. Results are from six replicates averaged together for the displayed data points. Data are from five different donors, with some donors repeated twice.</p></sec><sec id="micc70012-sec-0012"><label>2.6</label><title>Confocal Immunofluorescence</title><p>For confocal microscopy, poly&#x02010;L&#x02010;lysine coated coverslips (GG&#x02010;12&#x02010;1.5&#x02010;PLL; Neuvitro, Camas, WA) were coated with Attachment Factor for 30&#x02009;min at 37&#x000b0;C and placed inside 12&#x02010;well plates for confluent seeding of HLMVECs in complete MV2 media. After monolayer formation, cells were treated with vehicle, CFH2+ or CFH3+ (1.0&#x02009;mg/mL) for 6&#x02009;h. Paraquat (2&#x02009;mM), a direct ROS inducer, and antimycin A (5 uM), a complex III inhibitor, were used as positive controls for ROS formation and mitochondrial function disruption, respectively. Treated HLMVECs were rinsed with PBS twice before fixation with 4% paraformaldehyde in PBS for 10&#x02009;min in the dark at room temperature. Cells were permeabilized after washing with PBS using 0.1% Triton X&#x02010;100 in PBS for 10&#x02009;min at room temperature. Coverslips were washed 3&#x000d7; with PBS before blocking in 10% normal donkey serum in PBS for 1&#x02009;h at room temperature. Coverslips were incubated with primary antibody overnight in blocking buffer at 4&#x000b0;C. Antibodies and dyes used were rabbit anti&#x02010;vascular&#x02010;endothelial cadherin [D87F2] (1:400, 2500S; Cell Signaling Tech) for junction labeling and cell segmentation, MitoTracker Orange (150&#x02009;nM, M7510; Invitrogen) for mitochondrial network analysis, and Hoechst (500&#x02009;ng/mL, H1398; Invitrogen) as a DNA counterstain. After primary incubation, coverslips were washed with PBS three times for 5&#x02009;min/wash, and incubated with the secondary antibodies donkey anti&#x02010;rabbit Alexa Fluor 488 (1:1000, A&#x02010;21206; Invitrogen) or donkey anti&#x02010;mouse Alexa Fluor 647 (1:1000, A&#x02010;31571; Invitrogen) for 1&#x02009;h at room temperature in the dark. After 3X PBS washes, the coverslips were mounted on glass slides with ProLong Diamond (P36961, Invitrogen) and allowed to cure before imaging. Slides were imaged on the Zeiss LS780 with a 63X oil&#x02010;immersion objective. Quantification of mitochondrial network changes was done via Fiji using the mitochondrial network analysis (MiNA) plugin as previously described [<xref rid="micc70012-bib-0027" ref-type="bibr">27</xref>, <xref rid="micc70012-bib-0028" ref-type="bibr">28</xref>]. Briefly, the mitochondria channel images (MitoTracker Orange) were preprocessed using a median filter, top hat filter, and contrast limited AHE (CLAHE) in that order before ridge detection for network analysis [<xref rid="micc70012-bib-0028" ref-type="bibr">28</xref>].</p></sec><sec id="micc70012-sec-0013"><label>2.7</label><title>Real&#x02010;Time Quantitative <styled-content style="fixed-case" toggle="no">PCR</styled-content>
</title><p>Total RNA from treated HLMVEC was extracted using Qiagen RNeasy Mini Kit (74104; Qiagen, Hilden, Germany) per the manufacturer's instructions. Total RNA of 1&#x02009;&#x003bc;g was used per 20&#x02009;&#x003bc;L of iScript cDNA Synthesis Kit (1708891; Bio&#x02010;Rad, Hercules, CA). Bio&#x02010;Rad Prime PCR primers and probes specific to mt&#x02010;ND4L (qHsaCEP0055828), mt&#x02010;CYB (qHsaCEP0055614), and GAPDH (qHsaCEP0041396) were used to analyze extracellular DNA with qPCR. Qualitative PCR amplifications were performed in a QuantStudio 3 (A28567, Applied Biosystems) thermocycler using TaqMan Advanced Fast Master Mix (4444557; Applied Biosystems) with the following program: (20&#x02009;s at 95&#x000b0;C; 40&#x02009;cycles of 1&#x02009;s at 95&#x000b0;C then 20&#x02009;s at 60&#x000b0;C). DNA from conditioned media, after centrifugation to remove debris or detached cells, of HLMVECs treated for 24&#x02009;h were purified using Qiagen Blood and Tissue kit (69506, Qiagen) per the manufacturer's instructions. Isolated DNA was quantified for mtDNA using primers and probes specific to mitochondrially encoded ND4L (mt&#x02010;ND4L).</p></sec><sec id="micc70012-sec-0014"><label>2.8</label><title>Patient Plasma</title><p>Plasma was previously collected from a prospective cohort of critically ill patients at Vanderbilt University Medical Center (written informed consent was obtained and approved by Vanderbilt Institutional Review Board, Protocol No. 051065). The Validating Acute Lung Injury biomarkers for Diagnosis (VALID) study cohort has been extensively characterized previously for biomarker and risk factor studies [<xref rid="micc70012-bib-0009" ref-type="bibr">9</xref>, <xref rid="micc70012-bib-0029" ref-type="bibr">29</xref>, <xref rid="micc70012-bib-0030" ref-type="bibr">30</xref>]. Plasma was obtained at enrollment, generally ICU day 2, from patients admitted to Vanderbilt Medical, Surgical, Trauma, and Cardiovascular ICUs at high risk of developing end organ dysfunction [<xref rid="micc70012-bib-0030" ref-type="bibr">30</xref>]. Cell&#x02010;free hemoglobin was previously measured by ELISA (ab157707, Abcam) according to manufacturer's instructions [<xref rid="micc70012-bib-0009" ref-type="bibr">9</xref>].</p></sec><sec id="micc70012-sec-0015"><label>2.9</label><title>Statistical Analysis</title><p>Statistical analysis was performed using GraphPad Prism v10. Comparisons between groups were made using Kruskal&#x02013;Wallis one&#x02010;way ANOVA with Dunnett's multiple&#x02010;comparisons test, with an adjusted significance value set at <italic toggle="yes">&#x003b1;</italic>&#x02009;=&#x02009;0.05. All graphs are shown with the median and interquartile range or violin plots unless stated otherwise.</p></sec></sec><sec sec-type="results" id="micc70012-sec-0016"><label>3</label><title>Results</title><sec id="micc70012-sec-0017"><label>3.1</label><title>
<styled-content style="fixed-case" toggle="no">CFH3</styled-content>+ Increases Cellular and Mitochondrial <styled-content style="fixed-case" toggle="no">ROS</styled-content>
</title><p>Hemoglobin redox cycles via the iron atom present in the heme moiety. Therefore, we sought to quantify the changes in ROS production after CFH exposure. We utilized MitoSOX Red to measure mitochondrial superoxide via flow cytometry. MitoSOX MFI was significantly elevated at 6&#x02009;h (536 (428&#x02013;607) vs. 253 (230&#x02013;302) MFI, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.0116) after CFH3+ treatment compared to vehicle (Figure&#x000a0;<xref rid="micc70012-fig-0001" ref-type="fig">1A</xref>). Treatment with antimycin A, an electron transport chain inhibitor, as a positive control also elevated MitoSOX MFI at 1&#x02009;h post&#x02010;treatment. We also measured cellular ROS using CellROX Deep Red and found that ROS was elevated significantly at 6 and 24&#x02009;h in the CFH3+ group compared to the vehicle and CFH2+ groups (Figure&#x000a0;<xref rid="micc70012-fig-0001" ref-type="fig">1B</xref>). Pretreatment with Hp ameliorated this increase in cellular ROS at the 24&#x02009;h timepoint for CFH3+ treated cells (Figure&#x000a0;<xref rid="micc70012-fig-0001" ref-type="fig">1C</xref>). Pretreatment with antioxidants MitoQ and vitamin C did not reduce CellROX fluorescence (Figure&#x000a0;<xref rid="micc70012-supitem-0001" ref-type="supplementary-material">S1</xref>). These data support that cellular ROS and superoxide are elevated during the acute 6 to 24&#x02009;h time period after CFH3+ treatment.</p><fig position="float" fig-type="FIGURE" id="micc70012-fig-0001"><label>FIGURE 1</label><caption><p>CFH3+ induces mitochondrial superoxide and cellular ROS formation. MitoSOX stained HLMVECs were treated for the indicated time points before being analyzed on a BD LSRFortessa in the PE channel. (A) Quantification by background adjusted MFI of MitoSOX staining of HLMVECs at the time points of 1, 6, and 24&#x02009;h. CellROX stained HLMVECs were imaged on a BioTek Lionheart FX microscope using the Cy5 filter set (628/685). (B) Quantification of CellROX Deep Red staining at the time points of 1, 6, and 24&#x02009;h. (C) Pre&#x02010;treatment with Hp for 1&#x02009;h reduced CellROX staining from CFH3+ exposure at 24&#x02009;h (Mann&#x02013;Whitney test). (A,C) <italic toggle="yes">n</italic>&#x02009;=&#x02009;6 from 3 donors (two male, one female), (B) <italic toggle="yes">n</italic>&#x02009;=&#x02009;7&#x02013;15 from 4 donors (two male, two female). *&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01&#x02009;, and ****&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.0001. Graphs show median with interquartile range.</p></caption><graphic xlink:href="MICC-32-e70012-g002" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="micc70012-sec-0018"><label>3.2</label><title>Spare Respiratory Capacity Significantly Increased From <styled-content style="fixed-case" toggle="no">CFH3</styled-content>+ Treatment</title><p>Elevated mitochondrial superoxide from CFH3+ treatment led us to hypothesize that oxidative respiration would be impaired from CFH treatment. To test the effects of CFH3+ on mitochondrial respiration, we utilized the Mito Stress Test assay on the Seahorse Analyzer. A representative OCR plot over time showed the changes in respiration that occur from CFH treatment (Figure&#x000a0;<xref rid="micc70012-fig-0002" ref-type="fig">2A</xref>). A significant increase was seen in maximal respiration (43.50 [39.64&#x02013;49.96] vs. 17.52 OCR [13.13&#x02013;21.41], <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.001) and spare respiratory capacity (30.61 [29.36&#x02013;37.78] vs. 7.83 [3.715&#x02013;10.63] OCR, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.004) when comparing CFH3+ and vehicle&#x02010;treated cells (Figure&#x000a0;<xref rid="micc70012-fig-0002" ref-type="fig">2C,D</xref>). No significant changes in basal respiration, proton leak, and ATP production were seen (Figure&#x000a0;<xref rid="micc70012-fig-0002" ref-type="fig">2B,E,F</xref>). The spare respiratory capacity is the cell's ability to respond to increases in energy needs and respiratory stress and has been implicated in cellular survival [<xref rid="micc70012-bib-0031" ref-type="bibr">31</xref>, <xref rid="micc70012-bib-0032" ref-type="bibr">32</xref>]. The increases in maximal respiration and spare respiratory capacity seen here contrast with previous experiments showing dysfunction of the mitochondrial network.</p><fig position="float" fig-type="FIGURE" id="micc70012-fig-0002"><label>FIGURE 2</label><caption><p>Treatment of endothelial monolayers with CFH3+ increases maximal respiration and spare respiratory capacity. Confluent HLMVEC monolayers were treated for 6&#x02009;h with CFH before room temp equilibration prior to analysis on the Seahorse Analyzer using the Mito Stress Test. Hp pretreatment was for 1&#x02009;h for the VEH&#x02009;+&#x02009;Hp1&#x02010;1 and CFH3++Hp1&#x02010;1 groups. (A) Normalized OCR data from donor 57F showing the change in oxygen consumption after the addition of oligomycin (~20&#x02009;min), FCCP (~40&#x02009;min), and rotenone and antimycin A (~60&#x02009;min). Quantification of metabolic parameters of (B) basal respiration, (C) maximal respiration, (D) spare respiratory capacity, (E) proton leak, and (F) ATP production. <italic toggle="yes">n</italic>&#x02009;=&#x02009;8 from 5 donors (three male, two female) with some donors repeated. **&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01.</p></caption><graphic xlink:href="MICC-32-e70012-g005" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="micc70012-sec-0019"><label>3.3</label><title>
<styled-content style="fixed-case" toggle="no">CFH3</styled-content>+ Reduces the Mitochondrial Area and Circularity</title><p>To test for changes in mitochondrial morphology in response to CFH we utilized confocal and transmission electron microscopy (TEM). HLMVECs stained with MitoTracker Orange were imaged via confocal microscopy, and images were processed and analyzed using the MiNA plugin for Fiji. Representative images show the mitochondrial network with the MiNA overlay that is used for parameter quantification (Figure&#x000a0;<xref rid="micc70012-fig-0003" ref-type="fig">3B&#x02013;E</xref>). Network analysis revealed that CFH3+ caused a significant 19% reduction in the total mitochondrial area compared to vehicle control (2363 vs. 2917 um<sup>2</sup>, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.0485). Positive control paraquat also decreased the mitochondrial area, but it was not statistically significant (Figure&#x000a0;<xref rid="micc70012-fig-0003" ref-type="fig">3A</xref>). Other parameters including branch length, summed branch length, network branches, and donuts were not significantly different than vehicle treated cells (Figure&#x000a0;<xref rid="micc70012-supitem-0001" ref-type="supplementary-material">S2</xref>). High&#x02010;resolution TEM showed that CFH3+ causes mitochondrial morphology changes including increased mean electron density and aspect ratio and decreased circularity (Figure&#x000a0;<xref rid="micc70012-fig-0003" ref-type="fig">3I&#x02013;K</xref>). Analysis of the fission protein DRP1 did not show changes at the RNA and protein levels (Figure&#x000a0;<xref rid="micc70012-supitem-0001" ref-type="supplementary-material">S3</xref>). The results show that the mitochondrial network is decreased in response to CFH3+ with individual mitochondrion becoming more oblong and less round.</p><fig position="float" fig-type="FIGURE" id="micc70012-fig-0003"><label>FIGURE 3</label><caption><p>CFH3+ induces mitochondrial morphological changes. (A) Quantification of the mitochondrial footprint per field of view using the Mitochondrial Network Analysis (MiNA) ImageJ plugin. Representative images of the MiNA output for (B) vehicle, (C) CFH2+, (D) CFH3+, and (E) Paraquat treated cells with nuclei highlighted (white arrows; scale bar&#x02009;=&#x02009;10 um). Representative TEM micrographs for (F) vehicle, (G) CFH2+, and (H) CFH3+ treated HLMVECs with circularity demonstration (red circles) and mitochondria highlighted (black arrows; scale bar&#x02009;=&#x02009;400&#x02009;nm). Quantification of mitochondrial morphology parameters of (I) mean electron density, (J) circularity (4pi (area/perimeter<sup>2</sup>)) and (K) aspect ratio (major axis: Minor axis). (A&#x02013;E) <italic toggle="yes">n</italic>&#x02009;=&#x02009;5, (F, vehicle) <italic toggle="yes">n</italic>&#x02009;=&#x02009;228, (G, CFH2+) <italic toggle="yes">n</italic>&#x02009;=&#x02009;163, (H, CFH3+) <italic toggle="yes">n</italic>&#x02009;=&#x02009;416. *&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01&#x02009;, and ****&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p></caption><graphic xlink:href="MICC-32-e70012-g003" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="micc70012-sec-0020"><label>3.4</label><title>Mitochondrial Mass Is Reduced by Treatment With <styled-content style="fixed-case" toggle="no">CFH</styled-content>
</title><p>We sought to evaluate if mitochondrial mass was decreased in response to CFH treatment using MitoTracker Green staining of HLVMECs to visualize mitochondria. In CFH3+ treated cells, we observed a significant decrease in MitoTracker Green MFI when compared to control cells beginning at the 1&#x02009;h timepoint (1557 [535.5&#x02013;1747] vs. 2121 [1867&#x02013;3473] MFI, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.0001) and persisting until 3&#x02009;h (1462 [625&#x02013;1565] vs. 1877 [1606&#x02013;1946] MFI, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.03) (Figure&#x000a0;<xref rid="micc70012-fig-0002" ref-type="fig">2A</xref>). Similar effects were seen at 6&#x02009;h but were not significant (1606 [675.5&#x02013;1652] vs. 1836 (1799&#x02013;1880) MFI, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.0589). The representative images demonstrate the change in MitoTracker Green staining over the time course of 1&#x02013;6&#x02009;h in CFH3+ treated HLMVECs (Figure&#x000a0;<xref rid="micc70012-fig-0004" ref-type="fig">4B&#x02013;E</xref>). Significant decreases in MitoTracker Green staining were also seen with both CFH2+ and paraquat, a direct ROS inducer, at the 1&#x02009;h timepoint (Figure&#x000a0;<xref rid="micc70012-fig-0004" ref-type="fig">4A</xref>). Decreases in mitochondrial mass at the earliest timepoint were seen with all groups but only CFH3+ had a reduction that persisted until the final 6&#x02009;h timepoint.</p><fig position="float" fig-type="FIGURE" id="micc70012-fig-0004"><label>FIGURE 4</label><caption><p>CFH3+ decreases mitochondrial mass. (A) Quantification of MitoGreen by object MFI based on the DNA counterstain. Representative images (Blue&#x02009;=&#x02009;nuclei, Green&#x02009;=&#x02009;mitochondria; scale bar&#x02009;=&#x02009;2000 um) from HLMVECs stained with MitoTracker Green and treated with (B) vehicle and CFH3+ at the (C) 1, (D) 3, and (E) 6&#x02009;h time points. <italic toggle="yes">n</italic>&#x02009;=&#x02009;6 from 3 donors (two male, one female). *&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ***&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, ****&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p></caption><graphic xlink:href="MICC-32-e70012-g004" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="micc70012-sec-0021"><label>3.5</label><title>
<styled-content style="fixed-case" toggle="no">CFH</styled-content> Induces Partial Depolarization of the Mitochondrial Network</title><p>To identify the mechanism by which the mitochondrial network was shrinking, we evaluated changes in mitochondrial polarization. The fluorogenic probe JC10 was used due to its shift in fluorescence from green (cytosolic) to red (mitochondria) based on localization. Treatment with FCCP for compensation was optimized to 30&#x02009;min with 2.5 uM FCCP (Figure&#x000a0;<xref rid="micc70012-supitem-0001" ref-type="supplementary-material">S4</xref>). A reduction in the red fluorescence (PE channel) of JC10 is seen upon depolarization of mitochondria within a cell. HLMVECs treated with both CFH2+ and CFH3+ had a significant reduction of ~50% in the PE:FITC ratio at the 6&#x02009;h timepoint when compared to vehicle control (Figure&#x000a0;<xref rid="micc70012-fig-0005" ref-type="fig">5A</xref>). Representative histograms of PE and FITC fluorescence show the significant decrease in PE fluorescence (Figure&#x000a0;<xref rid="micc70012-fig-0005" ref-type="fig">5B</xref>) and shift towards a higher FITC MFI (Figure&#x000a0;<xref rid="micc70012-fig-0005" ref-type="fig">5C</xref>). Treatment of HLMVECs with CFH induces a significant depolarization of the mitochondrial network. This may partially explain the loss of mitochondria seen in previous experiments (Figure&#x000a0;<xref rid="micc70012-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="micc70012-fig-0005"><label>FIGURE 5</label><caption><p>CFH causes partial depolarization of mitochondria. (A) Quantification of the shift in fluorescence by the ratio of PE:FITC channels. Representative stacked histograms of the JC10 stained cells in the (B) PE and (C) FITC filter sets. <italic toggle="yes">n</italic>&#x02009;=&#x02009;12 from 3 donors (two male, one female). **&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></caption><graphic xlink:href="MICC-32-e70012-g001" position="anchor" id="jats-graphic-9"/></fig></sec><sec id="micc70012-sec-0022"><label>3.6</label><title>
<styled-content style="fixed-case" toggle="no">CFH3</styled-content>+ Induces Activation of the Mitochondrial Permeability Transition Pore Leading to <styled-content style="fixed-case" toggle="no">mtDNA</styled-content> Release</title><p>Increased ROS and mitochondrial depolarization informed our decision to quantify activation of the mPTP, which is implicated in both conditions [<xref rid="micc70012-bib-0033" ref-type="bibr">33</xref>]. Prolonged activation of the mPTP depolarizes mitochondria and leads to the release of mitochondrial contents into the cytosol. A flow cytometric assay using a combination of Calcein&#x02010;AM and cobalt chloride allows for selective staining of mitochondria with inactive mPTP. A significant decrease in the MFI was seen after CFH3+ treatment (1434 [874&#x02013;1642] vs. 2302 [1729&#x02013;2654] MFI, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.02) when compared to vehicle control (Figure&#x000a0;<xref rid="micc70012-fig-0006" ref-type="fig">6A</xref>). Activation of the mPTP allows for cobalt chloride to enter the mitochondria and quench the calcein fluorescence. A representative stacked histogram for the FITC channel shows the decrease in MFI that occurs after 6&#x02009;h of CFH3+ treatment (Figure&#x000a0;<xref rid="micc70012-fig-0006" ref-type="fig">6B</xref>). We sought to identify if mtDNA, a damage associated molecular pattern, was released after CFH3+ exposure into the extracellular space. Purified DNA from conditioned media was quantified using qPCR with probes specific to mt&#x02010;ND4L and expressed as the 1/Cq, so an increase in abundance aligns with an increase in the plotted value. A significant increase in the 1/Cq value was found for CFH3+ treated HLMVECs after 24&#x02009;h of exposure (Figure&#x000a0;<xref rid="micc70012-fig-0006" ref-type="fig">6C</xref>). In addition, we sought to identify if circulating mtDNA is associated with CFH concentration in patient plasma. DNA from plasma collected from critically ill patients was purified and the mt&#x02010;ND4L copy number was quantified using ddPCR (Table&#x000a0;<xref rid="micc70012-tbl-0001" ref-type="table">1</xref>). A Spearman correlation with previously measured CFH levels showed a weak association between circulating mtDNA and CFH (<italic toggle="yes">R</italic>
<sup>2</sup>&#x02009;=&#x02009;0.1912, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.0077) in patient plasma (Figure&#x000a0;<xref rid="micc70012-fig-0006" ref-type="fig">6D</xref>).</p><fig position="float" fig-type="FIGURE" id="micc70012-fig-0006"><label>FIGURE 6</label><caption><p>CFH3+ activates the mPTP and induces release of mtDNA. (A) Quantification of HLMVECs stained with calcein&#x02010;AM and cobalt chloride measured by MFI. (B) Representative stacked histogram of the FITC fluorescence shift from CFH3+ treatment. (C) Quantification of the change in mtDNA release in the media supernatant by qPCR. (D) Quantification of the circulating mtDNA copy number by ddPCR in patient plasma in association with CFH levels. Probes are specific to the mt&#x02010;ND4L gene. (A) <italic toggle="yes">n</italic>&#x02009;=&#x02009;7 from 3 donors (two male, one female), (C) <italic toggle="yes">n</italic>&#x02009;=&#x02009;14 from 5 donors (three male, two female), and (D) <italic toggle="yes">n</italic>&#x02009;=&#x02009;36. *&#x02009;=&#x02009;<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic xlink:href="MICC-32-e70012-g006" position="anchor" id="jats-graphic-11"/></fig><table-wrap position="float" id="micc70012-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Patient demographics for association between mtDNA and CFH in patient plasma.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>&#x02009;=&#x02009;36 (%)</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="2" valign="top" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="top" rowspan="1" colspan="1">13 (36%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">23 (64%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">White</td><td align="center" valign="top" rowspan="1" colspan="1">33 (92%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">55 (44, 71)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APACHE II Score on enrollment</td><td align="center" valign="top" rowspan="1" colspan="1">32.5 (27.8, 37.0)<xref rid="micc70012-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lived</td><td align="center" valign="top" rowspan="1" colspan="1">28 (78%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Died</td><td align="center" valign="top" rowspan="1" colspan="1">8 (22%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mechanical ventilation</td><td align="center" valign="top" rowspan="1" colspan="1">34 (94%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Berlin ARDS</td><td align="center" valign="top" rowspan="1" colspan="1">16 (44%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sepsis on any Day</td><td align="center" valign="top" rowspan="1" colspan="1">30 (83%)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Number of PRBC<xref rid="micc70012-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref> transfusions on enrollment</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">27 (75%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2.8%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3 (8.3%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">4 (11%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2.8%)</td></tr></tbody></table><table-wrap-foot id="micc70012-ntgp-0002"><fn id="micc70012-note-0002"><label>
<sup>a</sup>
</label><p>Median (IQR).</p></fn><fn id="micc70012-note-0003"><label>
<sup>b</sup>
</label><p>Packed red blood cell.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="micc70012-sec-0023"><label>4</label><title>Discussion</title><p>In this study, we demonstrate the CFH3+ causes significant changes to the mitochondrial network, including a decrease in area and mass, mitochondrial elongation, superoxide production, and partial depolarization. We found an increase in mtDNA release into the conditioned media potentially mediated by activation of the mPTP by CFH3+. Contrasting these results, which indicate deleterious defects to the mitochondrial network, metabolic analysis showed significant increases to maximal respiration and spare respiratory capacity, while basal respiration remained unchanged.</p><p>CFH has several effects on the microvasculature. We previously reported that the treatment of the pulmonary endothelium with CFH results in decreased transendothelial electrical resistance and endothelial activation [<xref rid="micc70012-bib-0017" ref-type="bibr">17</xref>, <xref rid="micc70012-bib-0018" ref-type="bibr">18</xref>]. These prior studies largely used commercially available CFH3+ without analyzing the effects of CFH2+ and CFH3+ in parallel. Commercial hemoglobin contains impurities that could influence experimental findings [<xref rid="micc70012-bib-0021" ref-type="bibr">21</xref>]. CFH3+ was shown to have a larger impact on activating the endothelium through pro&#x02010;inflammatory cytokine production and that the oxidation of CFH was required for endothelial injury [<xref rid="micc70012-bib-0034" ref-type="bibr">34</xref>, <xref rid="micc70012-bib-0035" ref-type="bibr">35</xref>]. We hypothesized that CFH3+ would induce mitochondrial dysfunction in pulmonary microvascular endothelial cells. The results from the experiments shown here demonstrate a clear difference in mitochondrial defects induced by CFH2+ vs. CFH3+ with only transient decreases in mitochondrial mass and polarization (Figures&#x000a0;<xref rid="micc70012-fig-0004" ref-type="fig">4</xref> and <xref rid="micc70012-fig-0005" ref-type="fig">5</xref>). This suggests that CFH alone in the native state has limited effects on mitochondrial function and requires oxidation to exert its effects. Our findings agree with previous studies of CFH&#x02010;induced endothelial dysfunction and demonstrate that CFH3+ is the primary driver of this dysfunction [<xref rid="micc70012-bib-0017" ref-type="bibr">17</xref>, <xref rid="micc70012-bib-0019" ref-type="bibr">19</xref>, <xref rid="micc70012-bib-0036" ref-type="bibr">36</xref>].</p><p>Myriad molecular pathways have been implicated in CFH&#x02010;mediated toxicity including TLR4, NLRP3, and ROS [<xref rid="micc70012-bib-0014" ref-type="bibr">14</xref>, <xref rid="micc70012-bib-0015" ref-type="bibr">15</xref>, <xref rid="micc70012-bib-0019" ref-type="bibr">19</xref>, <xref rid="micc70012-bib-0024" ref-type="bibr">24</xref>]. Elevated ROS in the endothelium impairs mitochondrial energetics and calcium homeostasis in atherosclerosis [<xref rid="micc70012-bib-0037" ref-type="bibr">37</xref>]. In addition, treatment of alveolar epithelial cells with CFH results in translocation of HO&#x02010;1, the heme detoxification enzyme, to the mitochondria and partial mitochondrial depolarization [<xref rid="micc70012-bib-0019" ref-type="bibr">19</xref>]. Our results reveal that multiple mitochondrial defects occur in response to CFH3+ but not CFH2+ treatment. The decrease in mitochondrial mass, area, and polarization supports this hypothesis and is aligned with the previous experiments showing severe barrier disruption and adhesion of leukocytes from CFH exposure [<xref rid="micc70012-bib-0017" ref-type="bibr">17</xref>, <xref rid="micc70012-bib-0018" ref-type="bibr">18</xref>]. Disruptions in both bulk mitochondria and functional polarized mitochondria pose significant challenges to maintaining oxidative phosphorylation and cellular viability. Without proper metabolism, cells will be unable to perform their vital functions in tissue homeostasis.</p><p>Mitochondrial morphology is an important determinant of mitochondrial function [<xref rid="micc70012-bib-0038" ref-type="bibr">38</xref>, <xref rid="micc70012-bib-0039" ref-type="bibr">39</xref>]. The mitochondrial network is dynamic and becomes fragmented, fused, or hyperfused depending on energy needs and oxidative stress [<xref rid="micc70012-bib-0040" ref-type="bibr">40</xref>]. Fission fragments mitochondria and is important for apoptotic induction and quality control of damaged mitochondria by mitophagy [<xref rid="micc70012-bib-0041" ref-type="bibr">41</xref>, <xref rid="micc70012-bib-0042" ref-type="bibr">42</xref>]. On the other hand, fusion of mitochondria results in an elongated and connected network of multiple mitochondria to respond to elevated energy needs or to increase electron transport chain (ETC) efficiency [<xref rid="micc70012-bib-0041" ref-type="bibr">41</xref>, <xref rid="micc70012-bib-0043" ref-type="bibr">43</xref>]. The decrease in roundness and circularity of the mitochondria treated with CFH3+ indicates elongation of the mitochondria and therefore the ability to respond to increased energy needs. The Seahorse data confirm this finding due to the highly significant increase in spare respiratory capacity, a measure of a cell's ability to respond to increased energy needs. Interestingly, the Seahorse assay showed no changes to basal respiration, proton leak, and ATP production, but significant increases in maximal respiration and spare respiratory capacity were seen from CFH3+ treatment. The spare respiratory capacity is a measure of the max respiratory rate of the ETC compared to basal respiration and represents the ability of a cell to respond to increased energy needs or stressful environments [<xref rid="micc70012-bib-0031" ref-type="bibr">31</xref>]. While we hypothesized that fission/fusion proteins would be involved, we did not see any changes in fission/fusion proteins. The absence of changes to basal respiration was surprising but not unexpected. The underlying mechanism of how CFH3+ increases spare respiratory capacity remains unknown [<xref rid="micc70012-bib-0031" ref-type="bibr">31</xref>]. Additional studies evaluating changes to both glycolytic rate and metabolic flux of fatty acids are needed to better understand the metabolic consequences of CFH exposure.</p><p>Elevated ROS from CFH is a known mechanism of CFH&#x02010;mediated toxicity and here we confirm that CFH3+ increases ROS [<xref rid="micc70012-bib-0015" ref-type="bibr">15</xref>, <xref rid="micc70012-bib-0019" ref-type="bibr">19</xref>, <xref rid="micc70012-bib-0044" ref-type="bibr">44</xref>]. Cycling of the iron molecule of heme generates ROS directly and increases oxidative damage [<xref rid="micc70012-bib-0015" ref-type="bibr">15</xref>, <xref rid="micc70012-bib-0019" ref-type="bibr">19</xref>]. HLMVECs treated with CFH3+ showed elevated cellular ROS and mitochondrial superoxide at the 6 and 24&#x02009;h timepoints. Attempts to reduce the ROS through antioxidants, such as vitamin C, MitoQ, and acetaminophen, were not effective in ameliorating the increase in ROS production (Figure&#x000a0;<xref rid="micc70012-supitem-0001" ref-type="supplementary-material">S1</xref>). Although elevated ROS is seen here, the antioxidants added may not be able to alleviate such a high dose of CFH or CFH could be acting indirectly to chronically produce ROS. Elevated ROS led us to look at downstream effectors that are activated by ROS. The mPTP has long been implicated in mediating pathologic mitochondrial dysfunction [<xref rid="micc70012-bib-0033" ref-type="bibr">33</xref>, <xref rid="micc70012-bib-0045" ref-type="bibr">45</xref>]. The mPTP is a large pore in the mitochondrial inner membrane that facilitates diffusion between the mitochondria and cytosol [<xref rid="micc70012-bib-0033" ref-type="bibr">33</xref>, <xref rid="micc70012-bib-0046" ref-type="bibr">46</xref>]. ROS, Ca<sup>2+</sup> ions, and ADP are known activators of the mPTP [<xref rid="micc70012-bib-0033" ref-type="bibr">33</xref>]. mPTP activation was significantly elevated after treatment with CFH3+. We further evaluated whether mtDNA, a molecule that can diffuse through the mPTP, was released from HLMVECs in higher amounts than vehicle or CFH&#x02010;treated cells. The increase of &#x02212;2 to 3 fold demonstrated that activation of the mPTP coincides with the release of mtDNA from CFH3+ treatment. As a clinical correlate, we observed an association between circulating CFH and mtDNA copy number in plasma from critically ill patients. Elevated ROS caused by CFH3+ may be an activator of the mPTP leading to the release of mtDNA from cells.</p><p>Our study has strengths and limitations. Studies were done in primary human lung microvascular endothelial cells from multiple donors of both sexes. In addition, we used multiple methods to evaluate many aspects of the endothelial mitochondria from mass and area to activation of the mPTP. However, we did not address the effects of CFH in&#x000a0;vivo. Whether these endothelial changes in response to CFH occur in&#x000a0;vivo is an unanswered question. The in&#x000a0;vitro studies presented here are in&#x02010;depth analyses of mitochondrial dynamic changes that are difficult to measure in whole tissue. Second, we identified novel differential effects of CFH 2+ and 3+ in ROS generation and induction of mitochondrial dysfunction, but the underlying mechanisms need to be explored further. A limitation of the study is the relatively low sample size that may obscure more subtle changes in mitochondrial parameters and provides less robust statistical performance. While the mPTP is activated by CFH3+, many other pathways are likely implicated in the complex mitochondrial changes seen here that warrant further investigation.</p></sec><sec id="micc70012-sec-0024"><label>5</label><title>Perspectives</title><p>The data presented here show that CFH3+ induces mitochondrial dysfunction in the pulmonary microvascular endothelium. This occurs alongside changes in mitochondrial shape and oxidative respiration, and the release of mtDNA from cells. In conditions associated with elevated CFH, mtDNA presents both a novel biomarker and therapeutic target.</p></sec><sec sec-type="conclusions" id="micc70012-sec-0025"><label>6</label><title>Conclusion</title><p>CFH3+ caused significant mitochondrial morphological changes alongside partial depolarization of the network. Mitochondrial maximal respiration was increased from CFH3+ treatment, leading to a significant increase in the spare respiratory capacity. Increased ROS and activation of the mPTP occurred, leading to the release of mtDNA from cells. This study presents a novel mechanism of CFH&#x02010;induced endothelial dysfunction that occurs through mitochondrial disruption.</p></sec><sec sec-type="conclusions" id="micc70012-sec-0030"><title>Consent</title><p>Written informed consent was obtained and approved by the Vanderbilt Institutional Review Board, Protocol No. 051065.</p></sec><sec sec-type="COI-statement" id="micc70012-sec-0029"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="micc70012-supitem-0001" position="float" content-type="local-data"><caption><p>
Figures&#x000a0;S1&#x02013;S4.
</p></caption><media xlink:href="MICC-32-e70012-s001.docx"/></supplementary-material></sec></body><back><ack id="micc70012-sec-0026"><title>Acknowledgments</title><p>This work was supported by HL150783, AG075341, GM144915, HL158906, and HL167471. Electron and confocal microscopy were performed in part through the use of the Vanderbilt Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, DK59637, EY08126, 1S10OD034315, 1S10RR027396, and 1R24OD037694). The purified haptoglobin used in this study was generously gifted by CSL Behring.</p></ack><sec sec-type="data-availability" id="micc70012-sec-0028"><title>Data Availability Statement</title><p>All data are available upon reasonable request to the corresponding author.</p></sec><ref-list content-type="cited-references" id="micc70012-bibl-0001"><title>References</title><ref id="micc70012-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="micc70012-cit-0001">
<string-name>
<given-names>C.</given-names>
<surname>Rhee</surname>
</string-name>, <string-name>
<given-names>T. M.</given-names>
<surname>Jones</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Hamad</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Prevalence, Underlying Causes, and Preventability of Sepsis&#x02010;Associated Mortality in US Acute Care Hospitals</article-title>,&#x0201d; <source>JAMA Network Open</source>
<volume>2</volume>, no. <issue>2</issue> (<year>2019</year>): <elocation-id>e187571</elocation-id>, <pub-id pub-id-type="doi">10.1001/JAMANETWORKOPEN.2018.7571</pub-id>.<pub-id pub-id-type="pmid">30768188</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="micc70012-cit-0002">
<collab collab-type="authors">Organization GWHO</collab>
, <article-title>&#x0201c;Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions,&#x0201d;</article-title> World Health Organization (<year>2020</year>).</mixed-citation></ref><ref id="micc70012-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="micc70012-cit-0003">
<string-name>
<given-names>M.</given-names>
<surname>Singer</surname>
</string-name>, <string-name>
<given-names>C. S.</given-names>
<surname>Deutschman</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Seymour</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis&#x02010;3)</article-title>,&#x0201d; <source>JAMA</source>
<volume>315</volume>, no. <issue>8</issue> (<year>2016</year>): <fpage>801</fpage>&#x02013;<lpage>810</lpage>, <pub-id pub-id-type="doi">10.1001/JAMA.2016.0287</pub-id>.<pub-id pub-id-type="pmid">26903338</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="micc70012-cit-0004">
<string-name>
<given-names>L. B.</given-names>
<surname>Ware</surname>
</string-name> and <string-name>
<given-names>M. A.</given-names>
<surname>Matthay</surname>
</string-name>, &#x0201c;<article-title>The Acute Respiratory Distress Syndrome</article-title>,&#x0201d; <source>New England Journal of Medicine</source>
<volume>342</volume>, no. <issue>18</issue> (<year>2000</year>): <fpage>1334</fpage>&#x02013;<lpage>1349</lpage>, <pub-id pub-id-type="doi">10.1056/NEJM200005043421806</pub-id>.<pub-id pub-id-type="pmid">10793167</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="micc70012-cit-0005">
<string-name>
<given-names>S.</given-names>
<surname>Godo</surname>
</string-name> and <string-name>
<given-names>H.</given-names>
<surname>Shimokawa</surname>
</string-name>, &#x0201c;<article-title>Endothelial Functions</article-title>,&#x0201d; <source>Arteriosclerosis, Thrombosis, and Vascular Biology</source>
<volume>37</volume>, no. <issue>9</issue> (<year>2017</year>): <fpage>e108</fpage>&#x02013;<lpage>e114</lpage>, <pub-id pub-id-type="doi">10.1161/ATVBAHA.117.309813</pub-id>.<pub-id pub-id-type="pmid">28835487</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="micc70012-cit-0006">
<string-name>
<given-names>A.</given-names>
<surname>Rengarajan</surname>
</string-name>, <string-name>
<given-names>H. E.</given-names>
<surname>Goldblatt</surname>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Beebe</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Virumbrales&#x02010;Mu&#x000f1;oz</surname>
</string-name>, and <string-name>
<given-names>D. S.</given-names>
<surname>Boeldt</surname>
</string-name>, &#x0201c;<article-title>Immune Cells and Inflammatory Mediators Cause Endothelial Dysfunction in a Vascular Microphysiological System</article-title>,&#x0201d; <source>Lab on a Chip</source>
<volume>24</volume>, no. <issue>6</issue> (<year>2024</year>): <fpage>1808</fpage>&#x02013;<lpage>1820</lpage>, <pub-id pub-id-type="doi">10.1039/D3LC00824J</pub-id>.<pub-id pub-id-type="pmid">38363157</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="micc70012-cit-0007">
<string-name>
<given-names>E.</given-names>
<surname>Dri</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Lampas</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Lazaros</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Inflammatory Mediators of Endothelial Dysfunction</article-title>,&#x0201d; <source>Life</source>
<volume>13</volume>, no. <issue>6</issue> (<year>2023</year>): <elocation-id>1420</elocation-id>, <pub-id pub-id-type="doi">10.3390/LIFE13061420</pub-id>.<pub-id pub-id-type="pmid">37374202</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="micc70012-cit-0008">
<string-name>
<given-names>J. E.</given-names>
<surname>Meegan</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Bastarache</surname>
</string-name>, and <string-name>
<given-names>L. B.</given-names>
<surname>Ware</surname>
</string-name>, &#x0201c;<article-title>Toxic Effects of Cell&#x02010;Free Hemoglobin on the Microvascular Endothelium: Implications for Pulmonary and Nonpulmonary Organ Dysfunction</article-title>,&#x0201d; <source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source>
<volume>321</volume>, no. <issue>2</issue> (<year>2021</year>): <fpage>L429</fpage>&#x02013;<lpage>L439</lpage>, <pub-id pub-id-type="doi">10.1152/AJPLUNG.00018.2021</pub-id>.<pub-id pub-id-type="pmid">34009034</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="micc70012-cit-0009">
<string-name>
<given-names>V.</given-names>
<surname>Eric Kerchberger</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Bastarache</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Shaver</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Haptoglobin&#x02010;2 Variant Increases Susceptibility to Acute Respiratory Distress Syndrome During Sepsis</article-title>,&#x0201d; <source>JCI Insight</source>
<volume>4</volume>, no. <issue>21</issue> (<year>2019</year>): <elocation-id>e131206</elocation-id>, <pub-id pub-id-type="doi">10.1172/JCI.INSIGHT.131206</pub-id>.<pub-id pub-id-type="pmid">31573976</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="micc70012-cit-0010">
<string-name>
<given-names>C. M.</given-names>
<surname>Shaver</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Wickersham</surname>
</string-name>, <string-name>
<given-names>J. B.</given-names>
<surname>McNeil</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Cell&#x02010;Free Hemoglobin&#x02010;Mediated Increases in Vascular Permeability. A Novel Mechanism of Primary Graft Dysfunction and a New Therapeutic Target</article-title>,&#x0201d; <source>Annals of the American Thoracic Society</source>
<volume>14</volume>, no. <issue>Supplement_3</issue> (<year>2017</year>): <fpage>S251</fpage>&#x02013;<lpage>S252</lpage>, <pub-id pub-id-type="doi">10.1513/ANNALSATS.201609-693MG</pub-id>.</mixed-citation></ref><ref id="micc70012-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="micc70012-cit-0011">
<string-name>
<given-names>S.</given-names>
<surname>Janciauskiene</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Vijayan</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Immenschuh</surname>
</string-name>, &#x0201c;<article-title>TLR4 Signaling by Heme and the Role of Heme&#x02010;Binding Blood Proteins</article-title>,&#x0201d; <source>Frontiers in Immunology</source>
<volume>11</volume> (<year>2020</year>): <elocation-id>1964</elocation-id>, <pub-id pub-id-type="doi">10.3389/FIMMU.2020.01964</pub-id>.<pub-id pub-id-type="pmid">32983129</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="micc70012-cit-0012">
<string-name>
<given-names>J. D.</given-names>
<surname>B</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>C</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>N</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Heme Triggers TLR4 Signaling Leading to Endothelial Cell Activation and Vaso&#x02010;Occlusion in Murine Sickle Cell Disease</article-title>,&#x0201d; <source>Blood</source>
<volume>123</volume>, no. <issue>3</issue> (<year>2014</year>): <fpage>377</fpage>&#x02013;<lpage>390</lpage>, <pub-id pub-id-type="doi">10.1182/BLOOD-2013-04-495887</pub-id>.<pub-id pub-id-type="pmid">24277079</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="micc70012-cit-0013">
<string-name>
<given-names>J.</given-names>
<surname>Balla</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Vercellotti</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Jeney</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Heme, Heme Oxygenase, and Ferritin: How the Vascular Endothelium Survives (and Dies) in an Iron&#x02010;Rich Environment</article-title>,&#x0201d; <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>9</volume>, no. <issue>12</issue> (<year>2007</year>): <fpage>2119</fpage>&#x02013;<lpage>2137</lpage>, <pub-id pub-id-type="doi">10.1089/ARS.2007.1787</pub-id>.<pub-id pub-id-type="pmid">17767398</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="micc70012-cit-0014">
<string-name>
<given-names>B. B.</given-names>
<surname>Nyakundi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>T&#x000f3;th</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Balogh</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Oxidized Hemoglobin Forms Contribute to NLRP3 Inflammasome&#x02010;Driven IL&#x02010;1&#x003b2; Production Upon Intravascular Hemolysis</article-title>,&#x0201d; <source>Biochimica et Biophysica Acta, Molecular Basis of Disease</source>
<volume>1865</volume>, no. <issue>2</issue> (<year>2019</year>): <fpage>464</fpage>&#x02013;<lpage>475</lpage>, <pub-id pub-id-type="doi">10.1016/J.BBADIS.2018.10.030</pub-id>.<pub-id pub-id-type="pmid">30389578</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="micc70012-cit-0015">
<string-name>
<given-names>T. L.</given-names>
<surname>Mollan</surname>
</string-name> and <string-name>
<given-names>A. I.</given-names>
<surname>Alayash</surname>
</string-name>, &#x0201c;<article-title>Redox Reactions of Hemoglobin: Mechanisms of Toxicity and Control</article-title>,&#x0201d; <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>18</volume>, no. <issue>17</issue> (<year>2013</year>): <fpage>2251</fpage>&#x02013;<lpage>2253</lpage>, <pub-id pub-id-type="doi">10.1089/ARS.2013.5195</pub-id>.<pub-id pub-id-type="pmid">23330885</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="micc70012-cit-0016">
<string-name>
<given-names>N.</given-names>
<surname>Posta</surname>
</string-name>, <string-name>
<given-names>&#x000c9;.</given-names>
<surname>Cs&#x00151;sz</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Oros</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Hemoglobin Oxidation Generates Globin&#x02010;Derived Peptides in Atherosclerotic Lesions and Intraventricular Hemorrhage of the Brain, Provoking Endothelial Dysfunction</article-title>,&#x0201d; <source>Laboratory Investigation</source>
<volume>100</volume>, no. <issue>7</issue> (<year>2020</year>): <fpage>986</fpage>&#x02013;<lpage>1002</lpage>, <pub-id pub-id-type="doi">10.1038/S41374-020-0403-X</pub-id>.<pub-id pub-id-type="pmid">32054994</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="micc70012-cit-0017">
<string-name>
<given-names>T.</given-names>
<surname>Tomasek</surname>
</string-name>, <string-name>
<given-names>L. B.</given-names>
<surname>Ware</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Bastarache</surname>
</string-name>, and <string-name>
<given-names>J. E.</given-names>
<surname>Meegan</surname>
</string-name>, &#x0201c;<article-title>Cell&#x02010;Free Hemoglobin&#x02010;Mediated Human Lung Microvascular Endothelial Barrier Dysfunction Is Not Mediated by Cell Death</article-title>,&#x0201d; <source>Biochemical and Biophysical Research Communications</source>
<volume>556</volume> (<year>2021</year>): <fpage>199</fpage>&#x02013;<lpage>206</lpage>, <pub-id pub-id-type="doi">10.1016/j.bbrc.2021.03.161</pub-id>.<pub-id pub-id-type="pmid">33848934</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="micc70012-cit-0018">
<string-name>
<given-names>A. K.</given-names>
<surname>Conger</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Tomasek</surname>
</string-name>, <string-name>
<given-names>K. J.</given-names>
<surname>Riedmann</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Hemoglobin Increases Leukocyte Adhesion and Initiates Lung Microvascular Endothelial Activation via Toll&#x02010;Like Receptor 4 Signaling</article-title>,&#x0201d; <source>American Journal of Physiology. Cell Physiology</source>
<volume>324</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>C665</fpage>&#x02013;<lpage>C673</lpage>, <pub-id pub-id-type="doi">10.1152/AJPCELL.00211.2022</pub-id>.<pub-id pub-id-type="pmid">36717098</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="micc70012-cit-0019">
<string-name>
<given-names>N. R.</given-names>
<surname>Chintagari</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jana</surname>
</string-name>, and <string-name>
<given-names>A. I.</given-names>
<surname>Alayash</surname>
</string-name>, &#x0201c;<article-title>Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells</article-title>,&#x0201d; <source>American Journal of Respiratory Cell and Molecular Biology</source>
<volume>55</volume>, no. <issue>2</issue> (<year>2016</year>): <fpage>288</fpage>&#x02013;<lpage>298</lpage>, <pub-id pub-id-type="doi">10.1165/RCMB.2015-0197OC</pub-id>.<pub-id pub-id-type="pmid">26974230</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="micc70012-cit-0020">
<string-name>
<given-names>M. A.</given-names>
<surname>Kluge</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Fetterman</surname>
</string-name>, and <string-name>
<given-names>J. A.</given-names>
<surname>Vita</surname>
</string-name>, &#x0201c;<article-title>Mitochondria and Endothelial Function</article-title>,&#x0201d; <source>Circulation Research</source>
<volume>112</volume>, no. <issue>8</issue> (<year>2013</year>): <fpage>1171</fpage>&#x02013;<lpage>1188</lpage>, <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.300233</pub-id>.<pub-id pub-id-type="pmid">23580773</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="micc70012-cit-0021">
<string-name>
<given-names>A.</given-names>
<surname>Afzal</surname>
</string-name>, <string-name>
<given-names>W. N.</given-names>
<surname>Beavers</surname>
</string-name>, <string-name>
<given-names>E. P.</given-names>
<surname>Skaar</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Ultraviolet Light Oxidation of Fresh Hemoglobin Eliminates Aggregate Formation Seen in Commercially Sourced Hemoglobin</article-title>,&#x0201d; <source>Blood Cells, Molecules &#x00026; Diseases</source>
<volume>98</volume> (<year>2023</year>): <elocation-id>102699</elocation-id>, <pub-id pub-id-type="doi">10.1016/J.BCMD.2022.102699</pub-id>.</mixed-citation></ref><ref id="micc70012-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="micc70012-cit-0022">
<string-name>
<given-names>J.</given-names>
<surname>Bejoy</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Farry</surname>
</string-name>, <string-name>
<given-names>E. S.</given-names>
<surname>Qian</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Ascorbate Protects Human Kidney Organoids From Damage Induced by Cell&#x02010;Free Hemoglobin</article-title>,&#x0201d; <source>Disease Models &#x00026; Mechanisms</source>
<volume>16</volume>, no. <issue>12</issue> (<year>2023</year>): <elocation-id>50342</elocation-id>, <pub-id pub-id-type="doi">10.1242/DMM.050342</pub-id>.</mixed-citation></ref><ref id="micc70012-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="micc70012-cit-0023">
<string-name>
<given-names>J. L.</given-names>
<surname>Kuck</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Bastarache</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Shaver</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Ascorbic Acid Attenuates Endothelial Permeability Triggered by Cell&#x02010;Free Hemoglobin</article-title>,&#x0201d; <source>Biochemical and Biophysical Research Communications</source>
<volume>495</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>433</fpage>&#x02013;<lpage>437</lpage>, <pub-id pub-id-type="doi">10.1016/J.BBRC.2017.11.058</pub-id>.<pub-id pub-id-type="pmid">29129689</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="micc70012-cit-0024">
<string-name>
<given-names>K. R.</given-names>
<surname>Schaaf</surname>
</string-name>, <string-name>
<given-names>S. R.</given-names>
<surname>Landstreet</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Pugazenthi</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Cell&#x02010;Free Hemoglobin Triggers Macrophage Cytokine Production via TLR4 and MyD88</article-title>,&#x0201d; <source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source>
<volume>326</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>L29</fpage>&#x02013;<lpage>L38</lpage>, <pub-id pub-id-type="doi">10.1152/AJPLUNG.00123.2023</pub-id>.<pub-id pub-id-type="pmid">37991487</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="micc70012-cit-0025">
<string-name>
<given-names>C. A.</given-names>
<surname>Schaer</surname>
</string-name>, <string-name>
<given-names>J. W.</given-names>
<surname>Deuel</surname>
</string-name>, <string-name>
<given-names>A. G.</given-names>
<surname>Bittermann</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mechanisms of Haptoglobin Protection Against Hemoglobin Peroxidation Triggered Endothelial Damage</article-title>,&#x0201d; <source>Cell Death and Differentiation</source>
<volume>20</volume>, no. <issue>11</issue> (<year>2013</year>): <fpage>1569</fpage>&#x02013;<lpage>1579</lpage>, <pub-id pub-id-type="doi">10.1038/cdd.2013.113</pub-id>.<pub-id pub-id-type="pmid">23995229</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="micc70012-cit-0026">
<string-name>
<given-names>R. C.</given-names>
<surname>Hart</surname>
</string-name>, <string-name>
<given-names>D. T.</given-names>
<surname>Carroll</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Vinogradova</surname>
</string-name>, and <string-name>
<given-names>E. S.</given-names>
<surname>Krystofiak</surname>
</string-name>, &#x0201c;<article-title>A Guide to Fixation and Staining of Biological Samples for Electron Microscopy</article-title>,&#x0201d; <source>Microscopy Today</source>
<volume>32</volume>, no. <issue>2</issue> (<year>2024</year>): <fpage>37</fpage>&#x02013;<lpage>40</lpage>, <pub-id pub-id-type="doi">10.1093/MICTOD/QAAE009</pub-id>.</mixed-citation></ref><ref id="micc70012-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="micc70012-cit-0027">
<string-name>
<given-names>J.</given-names>
<surname>Schindelin</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Arganda&#x02010;Carreras</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Frise</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Fiji: An Open&#x02010;Source Platform for Biological&#x02010;Image Analysis</article-title>,&#x0201d; <source>Nature Methods</source>
<volume>9</volume>, no. <issue>7</issue> (<year>2012</year>): <fpage>676</fpage>&#x02013;<lpage>682</lpage>, <pub-id pub-id-type="doi">10.1038/NMETH.2019</pub-id>.<pub-id pub-id-type="pmid">22743772</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="micc70012-cit-0028">
<string-name>
<given-names>A. J.</given-names>
<surname>Valente</surname>
</string-name>, <string-name>
<given-names>L. A.</given-names>
<surname>Maddalena</surname>
</string-name>, <string-name>
<given-names>E. L.</given-names>
<surname>Robb</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Moradi</surname>
</string-name>, and <string-name>
<given-names>J. A.</given-names>
<surname>Stuart</surname>
</string-name>, &#x0201c;<article-title>A Simple ImageJ Macro Tool for Analyzing Mitochondrial Network Morphology in Mammalian Cell Culture</article-title>,&#x0201d; <source>Acta Histochemica</source>
<volume>119</volume>, no. <issue>3</issue> (<year>2017</year>): <fpage>315</fpage>&#x02013;<lpage>326</lpage>, <pub-id pub-id-type="doi">10.1016/J.ACTHIS.2017.03.001</pub-id>.<pub-id pub-id-type="pmid">28314612</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="micc70012-cit-0029">
<string-name>
<given-names>L. B.</given-names>
<surname>Ware</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Koyama</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Derivation and Validation of a Two&#x02010;Biomarker Panel for Diagnosis of ARDS in Patients With Severe Traumatic Injuries</article-title>,&#x0201d; <source>Trauma Surgery &#x00026; Acute Care Open</source>
<volume>2</volume>, no. <issue>1</issue> (<year>2017</year>): <elocation-id>e000121</elocation-id>, <pub-id pub-id-type="doi">10.1136/TSACO-2017-000121</pub-id>.<pub-id pub-id-type="pmid">29766112</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="micc70012-cit-0030">
<string-name>
<given-names>L. B.</given-names>
<surname>Ware</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Koyama</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Biomarkers of Lung Epithelial Injury and Inflammation Distinguish Severe Sepsis Patients With Acute Respiratory Distress Syndrome</article-title>,&#x0201d; <source>Critical Care</source>
<volume>17</volume>, no. <issue>5</issue> (<year>2013</year>): <fpage>R253</fpage>, <pub-id pub-id-type="doi">10.1186/CC13080</pub-id>.<pub-id pub-id-type="pmid">24156650</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="micc70012-cit-0031">
<string-name>
<given-names>P.</given-names>
<surname>Marchetti</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Fovez</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Germain</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Khamari</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Kluza</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Spare Respiratory Capacity: Mechanisms, Regulation, and Significance in Non&#x02010;Transformed and Cancer Cells</article-title>,&#x0201d; <source>FASEB Journal</source>
<volume>34</volume>, no. <issue>10</issue> (<year>2020</year>): <fpage>13106</fpage>&#x02013;<lpage>13124</lpage>, <pub-id pub-id-type="doi">10.1096/FJ.202000767R</pub-id>.<pub-id pub-id-type="pmid">32808332</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="micc70012-cit-0032">
<string-name>
<given-names>G. J. W.</given-names>
<surname>van der Windt</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Everts</surname>
</string-name>, <string-name>
<given-names>C. H.</given-names>
<surname>Chang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development</article-title>,&#x0201d; <source>Immunity</source>
<volume>36</volume>, no. <issue>1</issue> (<year>2012</year>): <fpage>68</fpage>&#x02013;<lpage>78</lpage>, <pub-id pub-id-type="doi">10.1016/J.IMMUNI.2011.12.007</pub-id>.<pub-id pub-id-type="pmid">22206904</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="micc70012-cit-0033">
<string-name>
<given-names>A. P.</given-names>
<surname>Halestrap</surname>
</string-name>, &#x0201c;<article-title>What Is the Mitochondrial Permeability Transition Pore?</article-title>,&#x0201d; <source>Journal of Molecular and Cellular Cardiology</source>
<volume>46</volume>, no. <issue>6</issue> (<year>2009</year>): <fpage>821</fpage>&#x02013;<lpage>831</lpage>, <pub-id pub-id-type="doi">10.1016/J.YJMCC.2009.02.021</pub-id>.<pub-id pub-id-type="pmid">19265700</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="micc70012-cit-0034">
<string-name>
<given-names>G.</given-names>
<surname>Silva</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Jeney</surname>
</string-name>, <string-name>
<given-names>&#x000c2;.</given-names>
<surname>Chora</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Larsen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Balla</surname>
</string-name>, and <string-name>
<given-names>M. P.</given-names>
<surname>Soares</surname>
</string-name>, &#x0201c;<article-title>Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>284</volume>, no. <issue>43</issue> (<year>2009</year>): <fpage>29582</fpage>&#x02013;<lpage>29595</lpage>, <pub-id pub-id-type="doi">10.1074/JBC.M109.045344</pub-id>.<pub-id pub-id-type="pmid">19700768</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="micc70012-cit-0035">
<string-name>
<given-names>X.</given-names>
<surname>Liu</surname>
</string-name> and <string-name>
<given-names>Z.</given-names>
<surname>Spolarics</surname>
</string-name>, &#x0201c;<article-title>Methemoglobin Is a Potent Activator of Endothelial Cells by Stimulating IL&#x02010;6 and IL&#x02010;8 Production and E&#x02010;Selectin Membrane Expression</article-title>,&#x0201d; <source>American Journal of Physiology. Cell Physiology</source>
<volume>285</volume>, no. <issue>5</issue> (<year>2003</year>): <fpage>C1036</fpage>&#x02013;<lpage>C1046</lpage>, <pub-id pub-id-type="doi">10.1152/AJPCELL.00164.2003</pub-id>.<pub-id pub-id-type="pmid">12839837</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="micc70012-cit-0036">
<string-name>
<given-names>J. E.</given-names>
<surname>Meegan</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Shaver</surname>
</string-name>, <string-name>
<given-names>N. D.</given-names>
<surname>Putz</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Cell&#x02010;Free Hemoglobin Increases Inflammation, Lung Apoptosis, and Microvascular Permeability in Murine Polymicrobial Sepsis</article-title>,&#x0201d; <source>PLoS One</source>
<volume>15</volume>, no. <issue>2</issue> (<year>2020</year>): <fpage>1</fpage>&#x02013;<lpage>16</lpage>, <pub-id pub-id-type="doi">10.1371/journal.pone.0228727</pub-id>.</mixed-citation></ref><ref id="micc70012-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="micc70012-cit-0037">
<string-name>
<given-names>K.</given-names>
<surname>Qu</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Yan</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Qin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondrial Dysfunction in Vascular Endothelial Cells and Its Role in Atherosclerosis</article-title>,&#x0201d; <source>Frontiers in Physiology</source>
<volume>13</volume> (<year>2022</year>): <elocation-id>1084604</elocation-id>, <pub-id pub-id-type="doi">10.3389/FPHYS.2022.1084604</pub-id>.<pub-id pub-id-type="pmid">36605901</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="micc70012-cit-0038">
<string-name>
<given-names>G.</given-names>
<surname>Twig</surname>
</string-name> and <string-name>
<given-names>O. S.</given-names>
<surname>Shirihai</surname>
</string-name>, &#x0201c;<article-title>The Interplay Between Mitochondrial Dynamics and Mitophagy</article-title>,&#x0201d; <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>14</volume>, no. <issue>10</issue> (<year>2011</year>): <fpage>1939</fpage>&#x02013;<lpage>1951</lpage>, <pub-id pub-id-type="doi">10.1089/ARS.2010.3779</pub-id>.<pub-id pub-id-type="pmid">21128700</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="micc70012-cit-0039">
<string-name>
<given-names>M.</given-names>
<surname>Picard</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>White</surname>
</string-name>, and <string-name>
<given-names>D. M.</given-names>
<surname>Turnbull</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Morphology, Topology, and Membrane Interactions in Skeletal Muscle: A Quantitative Three&#x02010;Dimensional Electron Microscopy Study</article-title>,&#x0201d; <source>Journal of Applied Physiology</source>
<volume>114</volume>, no. <issue>2</issue> (<year>2013</year>): <fpage>161</fpage>&#x02013;<lpage>171</lpage>, <pub-id pub-id-type="doi">10.1152/JAPPLPHYSIOL.01096.2012</pub-id>.<pub-id pub-id-type="pmid">23104694</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="micc70012-cit-0040">
<string-name>
<given-names>D. A.</given-names>
<surname>Rube</surname>
</string-name> and <string-name>
<given-names>A. M.</given-names>
<surname>van der Bliek</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Morphology Is Dynamic and Varied</article-title>,&#x0201d; <source>Molecular and Cellular Biochemistry</source>
<volume>256&#x02013;257</volume>, no. <issue>1&#x02013;2</issue> (<year>2004</year>): <fpage>331</fpage>&#x02013;<lpage>339</lpage>, <pub-id pub-id-type="doi">10.1023/B:MCBI.0000009879.01256.F6</pub-id>.</mixed-citation></ref><ref id="micc70012-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="micc70012-cit-0041">
<string-name>
<given-names>M.</given-names>
<surname>Adebayo</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Singh</surname>
</string-name>, <string-name>
<given-names>A. P.</given-names>
<surname>Singh</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Dasgupta</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Fusion and Fission: The Fine&#x02010;Tune Balance for Cellular Homeostasis</article-title>,&#x0201d; <source>FASEB Journal</source>
<volume>35</volume>, no. <issue>6</issue> (<year>2021</year>): <elocation-id>e21620</elocation-id>, <pub-id pub-id-type="doi">10.1096/FJ.202100067R</pub-id>.<pub-id pub-id-type="pmid">34048084</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="micc70012-cit-0042">
<string-name>
<given-names>B.</given-names>
<surname>Westermann</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Fusion and Fission in Cell Life and Death</article-title>,&#x0201d; <source>Nature Reviews Molecular Cell Biology</source>
<volume>11</volume>, no. <issue>12</issue> (<year>2010</year>): <fpage>872</fpage>&#x02013;<lpage>884</lpage>, <pub-id pub-id-type="doi">10.1038/nrm3013</pub-id>.<pub-id pub-id-type="pmid">21102612</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="micc70012-cit-0043">
<string-name>
<given-names>B.</given-names>
<surname>Westermann</surname>
</string-name>, &#x0201c;<article-title>Bioenergetic Role of Mitochondrial Fusion and Fission</article-title>,&#x0201d; <source>Biochimica et Biophysica Acta</source>
<volume>1817</volume>, no. <issue>10</issue> (<year>2012</year>): <fpage>1833</fpage>&#x02013;<lpage>1838</lpage>, <pub-id pub-id-type="doi">10.1016/J.BBABIO.2012.02.033</pub-id>.<pub-id pub-id-type="pmid">22409868</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="micc70012-cit-0044">
<string-name>
<given-names>T.</given-names>
<surname>Kassa</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jana</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Meng</surname>
</string-name>, and <string-name>
<given-names>A. I.</given-names>
<surname>Alayash</surname>
</string-name>, &#x0201c;<article-title>Differential Heme Release From Various Hemoglobin Redox States and the Upregulation of Cellular Heme Oxygenase&#x02010;1</article-title>,&#x0201d; <source>FEBS Open Bio</source>
<volume>6</volume>, no. <issue>9</issue> (<year>2016</year>): <fpage>876</fpage>&#x02013;<lpage>884</lpage>, <pub-id pub-id-type="doi">10.1002/2211-5463.12103</pub-id>.</mixed-citation></ref><ref id="micc70012-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="micc70012-cit-0045">
<string-name>
<given-names>D.</given-names>
<surname>Hausenloy</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Wynne</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Duchen</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Yellon</surname>
</string-name>, &#x0201c;<article-title>Transient Mitochondrial Permeability Transition Pore Opening Mediates Preconditioning&#x02010;Induced Protection</article-title>,&#x0201d; <source>Circulation</source>
<volume>109</volume>, no. <issue>14</issue> (<year>2004</year>): <fpage>1714</fpage>&#x02013;<lpage>1717</lpage>, <pub-id pub-id-type="doi">10.1161/01.CIR.0000126294.81407.7D</pub-id>.<pub-id pub-id-type="pmid">15066952</pub-id>
</mixed-citation></ref><ref id="micc70012-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="micc70012-cit-0046">
<string-name>
<given-names>M.</given-names>
<surname>Patrushev</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Kasymov</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Patrusheva</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Ushakova</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Gogvadze</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Gaziev</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Permeability Transition Triggers the Release of mtDNA Fragments</article-title>,&#x0201d; <source>Cellular and Molecular Life Sciences: CMLS</source>
<volume>61</volume>, no. <issue>24</issue> (<year>2004</year>): <fpage>3100</fpage>&#x02013;<lpage>3103</lpage>, <pub-id pub-id-type="doi">10.1007/S00018-004-4424-1</pub-id>.<pub-id pub-id-type="pmid">15583871</pub-id>
</mixed-citation></ref></ref-list></back></article>